FDA-Drug2026-10-07Class IIPROCESSING DEFECT
Ajanta Pharma Ranolazine Extended-Release Tablets recalled for failed dissolution
What this means
Ajanta Pharma USA Inc. is recalling one lot of Ranolazine Extended-Release Tablets, 1000 mg, because the tablets failed to meet dissolution specifications. This means the medication may not release properly in the body, potentially affecting its effectiveness. The recall affects lot DJ25134 with an expiration date of 11/30/2028, distributed nationwide.
- Check if you have lot DJ25134 (printed on the bottle label).
- If you have this lot, contact your pharmacist or doctor before stopping this medication.
- Do not flush or throw away the medication without guidance; ask your pharmacist how to dispose of it safely.
- Contact Ajanta Pharma USA Inc. or the FDA with questions.
The agency's original wording
Hazard
Failed Dissolution Specifications: below specification
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the US.
Manufactured in
400 Crossing Blvd Ste 102, Bridgewater, NJ, United States
Products
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0010-2027More Ajanta Pharma recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.